In this report, we find that CD47 upregulation in melanoma occurs at the mRNA level and is associated with changes in chromatin accessibility at the CD47 promoter region using the assay for transposase-accessible chromatin with sequencing (ATAC-seq). The gene discussed is CD47; the disease is melanoma.